MedPath

Comparison of low-dose naloxone with ondansetron for prophylaxis of sufentanil- postoperative nausea and vomiting

Phase 3
Recruiting
Conditions
ause and vomiting.
Nausea and vomiting
Registration Number
IRCT20160307026950N52
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

All the patients who undergone general anesthesia with Sufntanil before surgery.

Exclusion Criteria

History of Asthma
History of chronic cough
Uppers respiratory tract infection
Hearth problems
History of anurism
Nephropatia
History of gastric retention
History of gastroesophageal reflux disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of nausea and vomiting after surgery. Timepoint: After surgery. Method of measurement: Checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath